Second Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements
Completed
Conditions studied: Corneal Endothelial Cell Loss
In brief
The primary objective of this clinical study is to collect additional clinical data to support an FDA 510(k) submission for the Topcon Specular Microscope SP-1P. The secondary objective is to evaluate any adverse events found during the clinical study.
Key facts
- Study ID
- NCT02427256
- Run by
- Topcon Medical Systems, Inc.
- People needed
- 76
- Starts
- 2015-02-01
- Expected to finish
- 2015-02-01
- Last updated by the study team
- 2022-06-08
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Andover Eye Associates — Andover, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.